China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)

Clinical trial NCT05221580 · COMPLETED

Trial details

NCT number: NCT05221580
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2022-03-18
Primary completion: 2023-03-31
Enrollment: 887

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.